Goldman Sachs Group »

Bicara Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.7M 233k 15.79
2025-03-31 $1.6M 126k 13.03
2024-12-31 $3.1M 180k 17.42
2024-09-30 $2.6M 102k 25.47